pilsicainide
DISEASE INTERVENTION COMPARISON RESULTS
Japanese Pharmacology and Therapeutics. 1995;23(7):113-120 Clinical Trial (non-controlled, non-randomized)
IN StudyID: Mizutani 1995, atrial fibrillation, paroxysmal The Use of
pilsicainide
As Treatment, Chronic
Is bad Than
no controls
To mortality, AF recurrence, adverse effects, pro-arrythmia - at 8 months
Am Heart J. 2000 Sep;140(3):437-44 Randomized Controlled Trial
IN StudyID: Okishige 2000, atrial fibrillation, persistent The Use of
pilsicainide
As Treatment, Chronic
Is better Than
placebo
To AF recurrence, mortality, adverse effects - at 12 and 24 months